Pyridostigmine Alternatives Compared
| Pyridostigmine | Mestinon | Azathioprine |
|
|---|
| Pyridostigmine | Mestinon (pyridostigmine) | Azathioprine |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Myasthenia Gravis, Reversal of Nondepolarizing Muscle Relaxants, Nerve Agent Pretreatment. May also be prescribed off label for Dysautonomia. |
Prescription only
Prescribed for Myasthenia Gravis, Reversal of Nondepolarizing Muscle Relaxants, Nerve Agent Pretreatment. May also be prescribed off label for Dysautonomia. |
Prescription only
Prescribed for Autoimmune Hepatitis, Atopic Dermatitis, Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Chronic Active Hepatitis, Crohn's Disease, Crohn's Disease - Acute, Crohn's Disease... View more |
Related suggestions Myasthenia Gravis
Popular comparisons
|
|||||||||||||||||||||||
| More about Pyridostigmine | More about Mestinon (pyridostigmine) | More about Azathioprine | ||||||||||||||||||||||||
| Generic Status | ||||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Pyridostigmine has an average rating of 6.8 out of 10 from a total of 49 ratings on Drugs.com. 57% of reviewers reported a positive effect, while 24% reported a negative effect. |
Mestinon has an average rating of 6.1 out of 10 from a total of 34 ratings on Drugs.com. 45% of reviewers reported a positive effect, while 32% reported a negative effect. |
Azathioprine has an average rating of 6.1 out of 10 from a total of 122 ratings on Drugs.com. 49% of reviewers reported a positive effect, while 33% reported a negative effect. |
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Side Effects | ||||||||||||||||||||||||||
|
See also: pyridostigmine side effects in more detail. |
See also: Mestinon side effects in more detail. |
Commonly reported side effects include:
See also: azathioprine side effects in more detail. |
||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all pyridostigmine prices |
View all Mestinon prices and generic prices |
View all azathioprine prices |
||||||||||||||||||||||||
| Dosage Form(s) Available | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
| Mestinon, Mestinon Timespan, Regonol | Other pyridostigmine brands include: Mestinon Timespan, Regonol | Azasan, Imuran | ||||||||||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||||||||||
|
N/A |
N/A |
2 hours |
||||||||||||||||||||||||
| CSA Schedule ** View glossary of terms | ||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 72 drugs are known to interact with pyridostigmine:
|
A total of 72 drugs are known to interact with Mestinon:
|
A total of 376 drugs are known to interact with azathioprine:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
April 06, 1955 |
April 06, 1955 |
March 20, 1968 |
||||||||||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient resources | ||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.